...)-HODE-d4 contains 4 deuterium atoms at the 9, 10,...n internal standard for the quantification of 13(S...is produced by incubation of linoleic acid with pl... to inhibit the adhesion of tumor cells to the end...
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
Cassette, Sal I from Takara Mirus Bio
Biology Products:(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Critical Zone Observatory seeks to answer climate change questions 10146 1Critical Zone Observatory seeks to answer climate change questions 10146 2Critical Zone Observatory seeks to answer climate change questions 10146 3Critical Zone Observatory seeks to answer climate change questions 10146 4Dr Richard Feinman to speak on the science of diabetes and diet on Oct 2 10142 1(Date:11/6/2009)..., QUINCY, Mass., Nov. 6 Myria... biotech developer and manufacturer of renewable ... preferred technology provider Uhde GmbH, one of t...y "Uhde"), announced an alliance for the engineeri...t,s biobased Succinic Acid plants based on renewab...
(Date:11/6/2009)..., HAYWARD, Calif., Nov. 6 Int...ns today on its ITCA 650 (DUROS® continuous d... type 2 diabetes at the Ninth Annual Diabetes Tech... http://www.newscom.com/cgi-bin/prnh/20050301/SFTU... of Exenatide Via ITCA 650 Lowers Plasma Glucose, ...
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DS...has made a manufacturing alliance with Galenix, Sa...eferred commercial scale manufacturing partner for..., DSM and Galenix will collaborate on business d... delivery technologies, based on the strength of G...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCal...TC ), a biopharmaceutical company developing first...ced its financial results for the third quarter en...happy that, in September of this year, the FDA,s A...d, by a vote of 12-0, the approval of XIAFLEX(TM) ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5